Recent Updates
Recently added Catalysts
OPCH Positive Sentiment Score: 65/100

Option Care Health Confirms Termination of Merger Agreement with Amedisys Highlights Strength of Platform and Track Record of Execution and Value Creation

Key Takeaway: Option Care Health has announced the termination of its merger agreement with Amedisys, which includes a $106 million termination fee that the company will integrate into its capital allocation strategy. The CEO emphasized the company’s resilience and ongoing commitment to creating shareholder value despite this setback. Option Care Health remains confident in its growth trajectory, supported by strong industry trends and its proven operational capabilities. This decision will allow the company to focus on enhancing its services in home and alternate site infusion.

Market Sentiment Analysis

POSITIVE FACTORS

  • Option Care Health receives a $106 million termination fee which will enhance shareholder value.
  • The company highlights its strong track record of execution and commitment to stakeholder value.
  • There are optimistic views on the growth trajectory based on current industry trends.

CONCERNS & RISKS

  • The termination of the merger with Amedisys may indicate challenges in consolidating business operations.
  • There is disappointment expressed by the CEO regarding the merger's outcome, reflecting potential uncertainty.

Full Press Release Details

Option Care Health Confirms Termination of Merger
Agreement with Amedisys
Highlights Strength of Platform and Track Record
of Execution and Value Creation
BANNOCKBURN, Ill., June 26, 2023 -- Option Care
Health, Inc. ("Option Care Health" or the "Company") (Nasdaq: OPCH) today announced that it has terminated
its previously announced agreement to combine with Amedisys, Inc. ("Amedisys").
As part of the mutual termination agreement, Option Care
Health will receive a $106 million termination fee. Consistent with Option Care Health's commitment to creating shareholder value,
the Company will incorporate the termination fee into its established capital allocation strategy.
"While we are disappointed in this outcome, Option
Care Health has a long track record of delivering value for our shareholders," said John C. Rademacher, President and Chief Executive
Officer of Option Care Health. "We take a disciplined approach to acquisitions and, as we evaluated our options, we applied this
discipline to ensure we continue to create value for all of our key stakeholders."
"Option Care Health benefits from a leading platform
in home and alternate site infusion services and a proven track record of execution," Rademacher continued. "We remain confident
in our growth trajectory, which is underpinned by current industry trends and market forces as well as our strong financial position.
Our team is committed to serving all our stakeholders by providing unsurpassed care and superior clinical outcomes in the home or ambulatory
setting, and we will continue to identify ways to increase the value we can deliver."
About Option Care Health
Option Care Health is the nation's largest independent
provider of home and alternate site infusion services. With over 7,500 team members including more than 4,500 clinicians, we work compassionately
to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise
and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn
more, please visit our website at OptionCareHealth.com.
Forward-Looking Statements - Safe Harbor
This press release may contain "forward-looking statements"
within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements
can be identified by words such as: "anticipate," "intend," "plan," "believe," "project,"
"estimate," "expect," "may," "should," "will" and similar references to future
periods. Examples of forward-looking statements include, among others, statements regarding our capital allocation plans and strategies.
Forward-looking statements are neither historical facts
nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the
future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions.
Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances
that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially
from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition
to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) changes in
laws and regulations applicable to our business model; (ii) changes in market conditions and receptivity to our services and offerings;
(iii) results of litigation; (iv) the loss of one or more key payers; (v) any adverse effect on the Company as a result
of the announcement filed as an exhibit to this report or the failure of the transaction to proceed; (vi) the Company's success
in executing its business plans and strategies and managing the risks involved in the foregoing; and (vii) changes to the Company's
capital allocation plans and strategies. For a detailed discussion of the risk factors that could affect our actual results and financial
condition, please refer to the risk factors identified in our SEC reports as filed with the SEC.
Any forward-looking statement made by us in this press release
is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation
to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of
new information, future developments or otherwise.
Chief Financial Officer
Arielle Rothstein / Sharon
Stern / Greg Klassen
Joele Frank, Wilkinson Brimmer

Frequently Asked Questions

Why did Option Care Health terminate the merger with Amedisys?

Option Care Health announced the termination of its merger with Amedisys to ensure value creation for stakeholders.

How much is the termination fee Option Care Health will receive?

Option Care Health will receive a $106 million termination fee as part of the agreement.

What is Option Care Health's focus moving forward?

The company aims to continue delivering high-quality care and superior clinical outcomes.

What services does Option Care Health provide?

Option Care Health is the largest independent provider of home and alternate site infusion services.

How many team members does Option Care Health have?

Option Care Health employs over 7,500 team members, including more than 4,500 clinicians.

Last updated: Jun 26, 2023